imatinib mesylate has been researched along with Neoplasms, Pleural in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordua, N; D'Antonio, F; De Vincenzo, F; Giordano, L; Perrino, M; Santoro, A; Zucali, PA | 1 |
| Bambara, HA; Lamien/Sanou, A; Ouédraogo Nde, NA; Ouédraogo, MS; Ouédraogo, NA; Tapsoba, GP; Thouraya Chtioui, A; Tiemtoré-Kambou, BM; Traoré, F; Zongo, N | 1 |
| D'Incalci, M; Davoli, E; Erba, E; Falcetta, F; Frapolli, R; Giordano, S; Licandro, SA; Matteo, C; Morosi, L; Ubezio, P; Visentin, S; Zucchetti, M | 1 |
| Fujimoto, J; Harun, N; Heymach, J; Hong, WK; Lee, JJ; Pisters, K; Tsao, AS; Wistuba, I | 1 |
| Agostini, M; Colombo, P; de Braud, F; De Pas, T; Manzotti, M; Pelosi, G; Toffalorio, F; Trifirò, G; Vigna, PD | 1 |
| Oka, M; Sakamoto, K; Tsutsui, M; Yoshino, S | 1 |
| Blank, SD; Butrynski, JE; Corless, CL; Dressel, DM; Ebrahim, KS; Heinrich, MC; Hornick, JL; Long, KB | 1 |
| Baas, P; Dalesio, O; Mathy, A; van Zandwijk, N | 1 |
| Mutti, L; Porta, C; Tassi, G | 1 |
| Barbone, D; Bertino, P; Busacca, S; Favoni, R; Gaudino, G; Germano, S; Mutti, L; Pinato, S; Porta, C; Tassi, G | 1 |
4 trial(s) available for imatinib mesylate and Neoplasms, Pleural
| Article | Year |
|---|---|
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Imatinib Mesylate; Male; Mesothelioma, Malignant; Pemetrexed; Pleural Neoplasms; Prognosis; Salvage Therapy; Survival Rate | 2020 |
Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cisplatin; Disease-Free Survival; Female; Glutamates; Guanine; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Maximum Tolerated Dose; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Piperazines; Pleural Neoplasms; Prognosis; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Survival Rate; Treatment Outcome | 2014 |
Limited efficacy of imatinib mesylate in malignant mesothelioma: a phase II trial.
Topics: Aged; Antineoplastic Agents; Benzamides; Disease Progression; Female; Humans; Imatinib Mesylate; Male; Mesothelioma; Middle Aged; Piperazines; Pleural Neoplasms; Pyrimidines; Survival Analysis; Treatment Outcome | 2005 |
Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease Progression; Female; Humans; Imatinib Mesylate; Male; Mesothelioma; Middle Aged; Pilot Projects; Piperazines; Pleural Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Stem Cell Factor; Treatment Failure | 2007 |
6 other study(ies) available for imatinib mesylate and Neoplasms, Pleural
| Article | Year |
|---|---|
Breast and pleuropulmonary metastasis of multirecurrent scalp dermatofibrosarcoma protuberans: a case report.
Topics: Adult; Alopecia; Antigens, CD34; Antineoplastic Agents; Biopsy; Breast Neoplasms; Cough; Dermatofibrosarcoma; Female; Humans; Imatinib Mesylate; Lung Neoplasms; Neoplasm Recurrence, Local; Pleural Neoplasms; Prognosis; Scalp; Skin Neoplasms; Treatment Outcome | 2017 |
Application of 3D Mass Spectrometry Imaging to TKIs.
Topics: Animals; Gold; Humans; Imaging, Three-Dimensional; Imatinib Mesylate; Mass Spectrometry; Metal Nanoparticles; Mice; Neoplasms, Mesothelial; Pleural Neoplasms; Protein Kinase Inhibitors; Tissue Distribution; Xenograft Model Antitumor Assays | 2017 |
Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura.
Topics: Adult; Benzamides; Female; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Piperazines; Pleural Neoplasms; Pneumonectomy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Solitary Fibrous Tumor, Pleural; Tomography, X-Ray Computed | 2008 |
[Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis].
Topics: Administration, Oral; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Mediastinum; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pleural Neoplasms; Pyrimidines; Rectal Neoplasms | 2009 |
Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation.
Topics: Anoctamin-1; Antineoplastic Agents; Atrial Fibrillation; Benzamides; Chloride Channels; Depression; Gastrointestinal Stromal Tumors; Humans; Hypercholesterolemia; Hypertension; Imatinib Mesylate; Immunohistochemistry; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Piperazines; Pleural Neoplasms; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Pyrimidines | 2010 |
Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Death; Deoxycytidine; Gemcitabine; Genes, fms; Glutamates; Guanine; Humans; Imatinib Mesylate; Mesothelioma; Pemetrexed; Piperazines; Pleural Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; Tumor Cells, Cultured | 2007 |